In addition, new compounds that selectively stabilize the G-quadruplex in mutant TERT promoters and inhibit telomerase expression have been evaluated in preclinical studies for their inhibitory effect on telomerase and killing of cancer cells (reviewed in (Song et al., 2019b; Tornesello et al., 2022b)). The gene discussed is TERT; the disease is cancer.